Patients with challenging cancers to benefit from genomic sequencing
12 February 2020 More than 1000 Victorian cancer patients are set to benefit from real-time genomic testing in the next three years, aiming to improve diagnosis and provide more targeted and effective treatments for cancers of unmet need.…
Work commences on a new global HQ
11 February 2020 World leading biotech company CSL has commenced construction of its global headquarters in Parkville, the nation’s premier biomedical precinct, which will further cement Melbourne’s position as a world class research destination The new purpose-built facility, which…
David McIntyre appointed as non-executive director
12 February 2020 Melbourne, Australia: The Board of Starpharma (ASX: SPL, OTCQX: SPHRY) is pleased to announce the appointment of Mr David McIntyre as an independent non-executive director, effective 1 March 2020. Mr McIntyre has more than 20 years…
Independent Plexaris and Cevaris testing shows positive and unique results
12 February 2020 Melbourne, Australia: BioMAP testing of Exopharm’s exosome platform has validated safety and mechanism of action (MOA) and found that they have different and distinct activities compared to 4,500 other drugs. This confirms this therapeutic approach…
ARDC funding outcomes: Monash receives current funding for future tech
5 February 2020 Monash University has secured $4.3m from the Australian Research Data Commons (ARDC) to lead four major data and cloud infrastructure science projects, which significantly advance the artificial intelligence (AI), data science and research technology capabilities…
Trajan’s hemaPEN included on TGA’s ARTG as first blood microsampling device for use in Australia
7 February 2020 Trajan Scientific and Medical’s hemaPEN® device has been included on the Australian Register of Therapeutic Goods (ARTG). The device enables the volumetrically accurate collection and storage of four dried blood spot (DBS) samples remote to the…
Milestone for HIV diagnostic
7 February 2020 Burnet Institute warmly welcomes Nigeria’s approval of a Burnet-developed diagnostic for adoption in the National HIV Control Program. The Omega VISITECT® CD4 350 test is a simple, low-cost rapid HIV diagnostic that can identify whether…
BioMelbourne Network Actions on the R&D Tax Incentive
8 February 2020 As you are aware, the Treasury Laws Amendment (Research and Development Tax Incentive) Bill 2019 (the Bill) was introduced to the House of Representatives on 5 December 2019. It will return to the House on…
New REDI grant funding validates ANDHealth model for digital health commercialisation
5 February 2020 ANDHealth will renew its commitment to turning innovative digital health ideas into commercial reality, after being named a beneficiary of a major new grant through its founding partner MTPConnect. The Federal Government’s Researcher Exchange and…
$5.5 million for international research collaborations in human health
6 February 2020 The Australian Government is investing $5.5 million in 10 ground-breaking medical research projects aimed at improving outcomes in mental health, dementia, aged care, cerebral palsy, diabetes and many more life-changing conditions. The Hon Greg Hunt…
Sienna makes Board Appointment
6 February 2020 ASX RELEASE Melbourne, Australia: Sienna Cancer Diagnostics Ltd (ASX:SDX) (“Sienna” or “the Company”) is pleased to announce the appointment of Tony Di Pietro as a Director of its Board. Tony has held the role of CFO and…
Sienna Increases European Presence Expanding into Finland with hTERT test
6 February 2020 ASX RELEASE Melbourne, Australia: Sienna Cancer Diagnostics Ltd (ASX:SDX) (“Sienna” or “the Company”) is pleased to announce the appointment of Immuno Diagnostic Oy as an exclusive distributor in Finland. The distribution agreement provides Immuno Diagnostic with the right…
